Famotidine for Oral Suspension, USP 40 mg/5 mL, Rx Only, Cherry-Banana-Mint Flavored, Not for Injection, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873. Distributed by: Gavis Pharmaceuticals, LLC, Somerset, NJ 08873, NDC 43386-500-11.
Published September 3, 2014 · Recall initiated: June 20, 2014
Summary
FDA records drug Class III recall D-1484-2014, published September 3, 2014 and initiated June 20, 2014. Recalling firm: Novel Laboratories, Inc.; Status: Terminated; Reported quantity: 25,776 containers; Lot: Lot #'s M13075A, M13076A, M13076B, M13077A, M13077B all with expiry dated 2/2015 and M13490A with expiry date 3/2016. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurity/Degradation Specification; 12-month stability time point
What to do
Voluntary: Firm initiated · Letter
Get an email if FAMOTIDINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FAMOTIDINE
- Manufacturer
- Novel Laboratories, Inc.
- Distributor
- Nationwide
- UPC
- 0343386500116
- Lot
- Lot #'s M13075A, M13076A, M13076B, M13077A, M13077B all with expiry dated 2/2015 and M13490A with expiry date 3/2016.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFamotidine Injection in Sodium Chloride Injection, 20 mg, 50 mL in GALAXY Single Dose Container, Rx Only,September 9, 2026
- FDAFamotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDCDecember 3, 2025
- FDAFamotidine Tablets, USP, 20mg, 200-count bottle within a carton, Distributed by: Glenmark Therapeutics Inc.,July 26, 2023
- FDAFamotidine Tablets USP 40mg, 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279March 10, 2021
- FDAVIVITROL (naltrexone for extended-release injectable suspension); 380 mg vial NDC 65757-300-01; RX OnlySeptember 3, 2014
- FDAPhilips IntelliSpace ECG Management System, with software option C61 needed to import ECGs from the QuintonAugust 27, 2014
Questions about this recall
Was Famotidine for Oral Suspension, USP 40 mg/5 mL, Rx Only, Cherry-Banana-Mint Flavored, Not for Injection, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873. Distributed by: Gavis Pharmaceuticals, LLC, Somerset, NJ 08873, NDC 43386-500-11. recalled?
Yes. FDA published recall D-1484-2014 on September 3, 2014. Reported hazard: Failed Impurity/Degradation Specification; 12-month stability time point
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FAMOTIDINE. UPC: 0343386500116.